Welcome to Healthscope Molecular
Healthscope Molecular is one of the largest providers of DNA-based testing in Australia, performing more than 150,000 tests per annum, and is the molecular diagnostic and biotechnology division of Healthscope Limited.
As well as providing clinical molecular diagnostics to the Healthscope Pathology division, Healthscope Molecular also has a strong research and development commitment. Healthscope Molecular’s current research program focuses on the clinical utility of pharmacogenomics, an area of great excitement for the improvement of individualised drug selection and dosing. Another area of research is in the clinical application of genomics, particularly in reference to cancer diagnosis.
Healthscope Molecular currently has purpose built laboratories within Gribbles Pathology (Melbourne) that are accredited by the National Association of Testing Authorities (NATA) to the international standard, ISO17025, with assay validation based on NPACC standards and guidelines.
If you wish to stay up-to-date with the latest in molecular medicine, click here to subscribe to Molecular Updates.